MREO (STOCKS)
Mereo BioPharma Group plc American Depositary Shares
$0.302500
-0.000400 (-0.13%)
Prev close: $0.302900
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Denise Vera Scots-Knight
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $49.07M
- Employees
- 36
- P/E (TTM)
- -1.73
- P/B (TTM)
- 1.69
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Research and Development | $15.02M |
| Operating Income/Loss | -$34.20M |
| Income/Loss From Continuing Operations After Tax | -$28.10M |
| Income/Loss From Continuing Operations Before Tax | -$28.10M |
| Income Tax Expense/Benefit | $0.00 |
| Interest Expense, Operating | $88.00K |
| Net Income/Loss | -$28.10M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$28.10M |
| Net Income/Loss Available To Common Stockholders, Basic | -$28.10M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.04 |
| Diluted Earnings Per Share | -$0.04 |
| Basic Average Shares | 2,406,416,020 |
| Diluted Average Shares | 2,406,416,020 |
| Assets | $34.71M |
| Current Assets | $33.40M |
| Noncurrent Assets | $1.31M |
| Fixed Assets | $54.00K |
| Other Non-current Assets | $1.26M |
| Liabilities | $6.06M |
| Current Liabilities | $5.68M |
| Accounts Payable | $1.12M |
| Other Current Liabilities | $4.56M |
| Noncurrent Liabilities | $385.00K |
| Equity | $28.65M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $28.65M |
| Liabilities And Equity | $34.71M |
| Net Cash Flow From Operating Activities | -$25.35M |
| Net Cash Flow From Operating Activities, Continuing | -$25.35M |
| Net Cash Flow From Investing Activities | $0.00 |
| Net Cash Flow From Investing Activities, Continuing | $0.00 |
| Net Cash Flow From Financing Activities | $10.91M |
| Net Cash Flow From Financing Activities, Continuing | $10.69M |
| Exchange Gains/Losses | -$700.00K |
| Net Cash Flow | -$14.91M |
| Net Cash Flow, Continuing | -$14.21M |
| Comprehensive Income/Loss | -$31.74M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$31.74M |
| Other Comprehensive Income/Loss | $17.16M |